All projected costs are estimates at this stage and may very well go higher still. Would seem to be in this range though.
Scoping study currently underway will no doubt determine more accurate Capex requirements.
SRR have shown themselves to be prudent financial managers to date, so I am comfortable with additional cash raising in Q4. Specific to Otjo, it's a case of spending money to make money. It is a near term, lower cost development in relative terms and revenue will flow soon after.
Whilst we don't want our investments to be diluted unnecessarily through too many additional shares on the register, a rights issue would also give us the chance to buy in and top up our holdings at a discount to the market.
I think we are all quietly confident that SP gains between now and then will add further weight to the continued growth and development of the company and help to justify any future fund raising.
Have a good week all.
SRR Price at posting:
22.3¢ Sentiment: LT Buy Disclosure: Held